Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 65 Records) |
| Query Trace: Colorectal Neoplasms and ERBB2[original query] |
|---|
| Detecting copy number alterations in RNA-Seq using SuperFreq. Bioinformatics (Oxford, England) 2021 6 . Flensburg Christoffer, Oshlack Alicia, Majewski Ian |
| An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report. Frontiers in oncology 2021 12 11 755578. Fang Tian, Liang Tingting, Wang Yizhuo, Wu Haitao, Liu Shuhan, Xie Linying, Zhang Zhihao, Liang Jiaying, Yao Cheng, Tan Yehui, Wang Cha |
| Mutation analysis of a 10-gene panel for colorectal cancer in Huizhou, Guangdong Province of China. The Journal of international medical research 2021 Nov 49 (11): 3000605211061040. Li Jun, Sun Aihua, Zhong Guofang, He Ying, Xiong Hailin, Yuan X |
| [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2021 10 43 (10): 1088-1093. Tang X J, Yang M Y, Zhu L Z, Xu D, Yuan |
| A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results. Oncology 2021 Oct 1-11. Wein Axel, Stoehr Robert, Kersting Stephan, Siebler Jürgen, Merkel Susanne, Busse Dagmar, Wolff Kerstin, Ostermeier Nicola, Neufert Clemens, Vitali Francesco, Eckstein Markus, Roth Jan-Peter, Anhut Peter, Schreiner Waldemar, Uder Michael, Hartmann Arndt, Neurath Markus F, Grützmann Robe |
| Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project. Cancer treatment and research communications 2022 Aug 33 100623. Bridgewater John, Jiao Xiaolong, Parimi Mounika, Flach Clare, Stratford Jeran, Kamburov Atanas, Schmitz Arndt A, Zong Jihong, Reeves John A, Keating Karen, Bruno Amanda, Fellous Marc, Pereira Mariana Buongermino, Bazhenova Lyudmi |
| Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 8 41 (3): 485-496. Topham James T, O'Callaghan Chris J, Feilotter Harriet, Kennecke Hagen F, Lee Young S, Li Weimin, Banks Kimberly C, Quinn Katie, Renouf Daniel J, Jonker Derek J, Tu Dongsheng, Chen Eric X, Loree Jonathan |
| Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience. JCO precision oncology 2022 6 6 e2100289. Gerratana Lorenzo, Movarek Michael, Wehbe Firas, Katam Neelima, Mahalingam Devalingam, Donahue Jeannine, Shah Ami, Chae Young K, Mulcahy Mary, Tsarwhas Dean, Villaflor Victoria, Kalyan Aparna, Hussein Maha, Patel Jyoti, Chandra Sunandana, Platanias Leonidas C, Gradishar William, Cristofanilli Massimo, Behdad Am |
| Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer. Targeted oncology 2022 Jun . Tan Elaine S, Fan Wenyi, Knepper Todd C, Schell Michael J, Sahin Ibrahim H, Fleming Jason B, Xie H |
| Correlation of KMT2 family mutations with molecular characteristics and prognosis in colorectal cancer. The International journal of biological markers 2022 Jun 37 (2): 149-157. Liao Cun, Huang Wei, Lin Minglin, Li Hui, Zhang Zihan, Zhang Xiaolong, Chen Rongrong, Huang Mingfeng, Yu Pengli, Zhang S |
| Mucinous Histology Is Associated with Resistance to Anti-EGFR Therapy in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer. The oncologist 2022 5 27 (2): 104-109. Wang Chongkai, Sandhu Jaideep, Fakih Marw |
| Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy. JCO precision oncology 2022 5 6 e2200037. Randon Giovanni, Maddalena Giulia, Germani Marco Maria, Pircher Chiara Carlotta, Manca Paolo, Bergamo Francesca, Giordano Mirella, Sposetti Caterina, Montagna Aldo, Vetere Guglielmo, Zambelli Luca, Rasola Cosimo, Boccaccino Alessandra, Pagani Filippo, Ambrosini Margherita, Massafra Marco, Fontanini Gabriella, Milione Massimo, Fassan Matteo, Cremolini Chiara, Lonardi Sara, Pietrantonio Filip |
| ERBB2 Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing. Frontiers in oncology 2022 4 12 769709. Wang Qi-Wen, Wang Xin-Yuan, Zhang Qing-Wei, Chen Jin-Nan, Zhou Yu-Jie, Tang Zhao-Rong, Wang Rui-Lan, Chen Haoyan, Chen Huimin, Li Xiao- |
| Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy. Frontiers in oncology 2022 3 12 830816. Yang Wentao, Zou Jianling, Li Ye, Liu Rujiao, Yan Zhengqing, Chen Shiqing, Zhao Xiaoying, Guo Weijian, Huang Mingzhu, Li Wenhua, Zhu Xiaodong, Chen Zhi |
| Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA oncology 2023 5 . Stefania Napolitano, Vincenzo De Falco, Giulia Martini, Davide Ciardiello, Erika Martinelli, Carminia Maria Della Corte, Lucia Esposito, Vincenzo Famiglietti, Alessandra Di Liello, Antonio Avallone, Claudia Cardone, Alfonso De Stefano, Vincenzo Montesarchio, Maria Giulia Zampino, Roberto Bordonaro, Mario Scartozzi, Daniele Santini, Massimo Di Maio, Ferdinando De Vita, Lucia Altucci, Francesca Marrone, Fortunato Ciardiello, Teresa Troia |
| Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer center network. Molecular oncology 2023 4 . Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, Xavier Pérez, Susana Aguilar, Fiorella Ruíz-Pace, Marta Gil, Carmen Cuadra, José Carlos Ruffinelli, Mercedes Martínez, Ferran Losa, Gema Soler, Àlex Teulé, Roser Castany, Rosa Gallego, Andrea Ruíz, Elena Garralda, Elena Élez, Ana Vivancos, Josep Tabernero, Ramon Salazar, Rodrigo Dienstmann, Cristina Sant |
| Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
| Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology. Journal of personalized medicine 2023 12 13 (12): . Soeren M Buchholz, Nelia Nause, Ute König, Johanna Reinecke, Benjamin Steuber, Christoph Ammer-Herrmenau, Kirsten Reuter-Jessen, Hanibal Bohnenberger, Lorenz Biggemann, Friederike Braulke, Albrecht Neesse, Volker Ellenrieder, Philipp Ströbel, Marius Adler, Alexander Kön |
| Progress report of a cross-organ and biomarker-based basket-type clinical trial: BELIEVE Trial. Cancer science 2023 12 . Yayoi Ando, Tatsunori Shimoi, Kuniko Sunami, Natsuko Okita, Kenichi Nakamura, Taro Shibata, Yasuhiro Fujiwara, Noboru Yamamo |
| Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population. PloS one 2023 10 18 (10): e0292087. Udit Nindra, Abhijit Pal, Vivienne Lea, Stephanie Hui-Su Lim, Kate Wilkinson, Ray Asghari, Tara L Roberts, Therese M Becker, Mahtab Farzin, Tristan Rutland, Mark Lee, Scott MacKenzie, Weng Ng, Bin Wang, C Soon Lee, Wei Ch |
| Fusobacterium Nucleatum-Induced Tumor Mutation Burden Predicts Poor Survival of Gastric Cancer Patients. Cancers 2023 1 15 (1): . Hsieh Yung-Yu, Kuo Wen-Lin, Hsu Wan-Ting, Tung Shui-Yi, Li Ch |
| Driver and targetable alterations in Chinese patients with small bowel carcinoma. Journal of cancer research and clinical oncology 2023 1 . Li Jun, Li Xiaomo, Dong Ningning, Yan Shu, Jing Chao, Ma Tonghui, Li Wei, Zhang Chenghai, Cai Yi, Deng W |
| A study of gene variation in All-RAS wild-type metastatic colorectal cancer and its correlation with cetuximab. Journal of gastrointestinal oncology 2023 1 13 (6): 3009-3024. Tao Huimin, Shen Meng, Zhang Xiaochang, Wang Minghui, Wu Yan, Sun Hui, Ling Chen, Yang Ying, Chen Kai, Li Dape |
| Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA (ctDNA) in Routine Clinical Practice. Oncology 2024 9 1-24. Shaheenah Dawood, Nippun Sandhir, Marwan Akasheh, Maroun El Khoury, Sonia Otsmane, Muath Alnassar, Omalkhair Abulkhair, Fadi Farhat, Steve Ols |
| Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2. Oncology research 2024 9 32 (9): 1429-1438. Yuzhi Liu, Evelyne Bischof, Zhiqin Chen, Jiahuan Zhou, Bei Zhang, Ding Zhang, Yong Gao, Ming Qu |
| Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants. Cancer biology & medicine 2024 6 21 (6): 473-83. Shuyi Chen, Jing Gu, Kaichun Wu, Xiaodi Zhao, Yuanyuan |
| Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay. BMC cancer 2024 12 24 (1): 1547. Mariana Bisarro Dos Reis, Wellington Dos Santos, Ana Carolina de Carvalho, Adhara Brandão Lima, Monise Tadin Reis, Florinda Santos, Rui Manuel Reis, Denise Peixoto Guimarã |
| HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01. Nature communications 2024 11 15 (1): 10213. Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, Kensei Yamaguchi, Tomohiro Nishina, Elena Elez, Javier Rodriguez, Ian Chau, Maria Di Bartolomeo, Hisato Kawakami, Fumitaka Suto, Makito Koga, Koichiro Inaki, Yusuke Kuwahara, Issey Takehara, Daniel Barrios, Kojiro Kobayashi, Axel Grothey, Takayuki Yoshi |
| Multigene Panel Next-Generation Sequencing Techniques in the Management of Patients with Metastatic Colorectal Carcinoma: The Way Forward for Personalized Treatment? A Single-Center Experience. International journal of molecular sciences 2024 10 25 (20): . Laura Matteucci, Francesco Giulio Sullo, Chiara Gallio, Luca Esposito, Margherita Muratore, Ilario Giovanni Rapposelli, Daniele Calistri, Elisabetta Petracci, Claudia Rengucci, Laura Capelli, Elisa Chiadini, Paola Ulivi, Alessandro Passardi, Alessandro Bitto |
| Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial. Nature medicine 2025 1 . Alicia F C Okines, Giuseppe Curigliano, Nobumasa Mizuno, Do-Youn Oh, Andree Rorive, Hatem Soliman, Shunji Takahashi, Tanios Bekaii-Saab, Mark E Burkard, Ki Y Chung, Philip R Debruyne, Jenny R Fox, Valentina Gambardella, Marta Gil-Martin, Erika P Hamilton, Bradley J Monk, Yoshiaki Nakamura, Danny Nguyen, David M O'Malley, Alexander B Olawaiye, Bhavana Pothuri, Martin Reck, Kazuki Sudo, Yu Sunakawa, Cedric Van Marcke, Evan Y Yu, Jorge Ramos, Sherry Tan, Mark Bieda, Thomas E Stinchcombe, Paula R Pohlma |
- Page last reviewed:Feb 1, 2024
- Content source: